Matches in Wikidata for { <http://www.wikidata.org/entity/Q91338790> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- Q91338790 description "article scientifique publié en 2018" @default.
- Q91338790 description "artículu científicu espublizáu en setiembre de 2018" @default.
- Q91338790 description "scientific article published on 05 September 2018" @default.
- Q91338790 description "wetenschappelijk artikel" @default.
- Q91338790 description "наукова стаття, опублікована у вересні 2018" @default.
- Q91338790 name "Ponatinib evaluation and safety in real-life chronic myelogenous leukemia patients failing more than two tyrosine kinase inhibitors: the PEARL observational study" @default.
- Q91338790 name "Ponatinib evaluation and safety in real-life chronic myelogenous leukemia patients failing more than two tyrosine kinase inhibitors: the PEARL observational study" @default.
- Q91338790 type Item @default.
- Q91338790 label "Ponatinib evaluation and safety in real-life chronic myelogenous leukemia patients failing more than two tyrosine kinase inhibitors: the PEARL observational study" @default.
- Q91338790 label "Ponatinib evaluation and safety in real-life chronic myelogenous leukemia patients failing more than two tyrosine kinase inhibitors: the PEARL observational study" @default.
- Q91338790 prefLabel "Ponatinib evaluation and safety in real-life chronic myelogenous leukemia patients failing more than two tyrosine kinase inhibitors: the PEARL observational study" @default.
- Q91338790 prefLabel "Ponatinib evaluation and safety in real-life chronic myelogenous leukemia patients failing more than two tyrosine kinase inhibitors: the PEARL observational study" @default.
- Q91338790 P1433 Q91338790-30C48185-53CF-45B9-BECA-8455F9D3B53A @default.
- Q91338790 P1476 Q91338790-5900ACAB-B894-4E7C-BD23-274F1ADA5AAE @default.
- Q91338790 P2093 Q91338790-1141CBC2-445B-410A-8E53-67C0493120E5 @default.
- Q91338790 P2093 Q91338790-2E32B498-3FF5-4F3E-BFB8-1EC8A7124213 @default.
- Q91338790 P2093 Q91338790-45FA472B-99EB-42FF-908A-BFD71244586F @default.
- Q91338790 P2093 Q91338790-49FC0437-C21F-4459-8537-20BA74370DF1 @default.
- Q91338790 P2093 Q91338790-5E560876-A61A-4C2E-8655-94BA1241B5AF @default.
- Q91338790 P2093 Q91338790-65DF72D6-D860-4486-8934-213F232F141A @default.
- Q91338790 P2093 Q91338790-7CE4A4DB-950F-4684-9D10-4FB519781873 @default.
- Q91338790 P2093 Q91338790-802DEBF3-1E1B-423D-AEF0-3A0C08A24FA8 @default.
- Q91338790 P2093 Q91338790-8C98CBEC-8C66-48E2-B843-9E16CA45C03A @default.
- Q91338790 P2093 Q91338790-9D245933-8D0D-45F5-AE1E-CF57AF6C9F81 @default.
- Q91338790 P2093 Q91338790-AE6959DA-0ECD-4712-8CBE-419C45C0ACA7 @default.
- Q91338790 P2093 Q91338790-B3B5093F-F385-42CA-89CF-381217710318 @default.
- Q91338790 P2093 Q91338790-B95EB3E2-D0A8-45BF-A556-EA729AAB2650 @default.
- Q91338790 P2093 Q91338790-BC4EC558-C09E-4881-8972-E0C2B92F56F5 @default.
- Q91338790 P2093 Q91338790-CDE9FF7B-BDBE-4B8D-8E9E-058303EB690C @default.
- Q91338790 P2093 Q91338790-EBAB80ED-A81B-4069-927B-C27B47B70611 @default.
- Q91338790 P2093 Q91338790-F0B1F865-7D8D-4689-9B47-8AD965F69D60 @default.
- Q91338790 P2093 Q91338790-F3363EE8-59A6-4C10-944D-BBAA48239AC8 @default.
- Q91338790 P2093 Q91338790-F463E833-D863-4E8E-80BC-CF37D8F389BC @default.
- Q91338790 P304 Q91338790-F32A148D-15B3-4045-B5D9-70A155AD74B0 @default.
- Q91338790 P31 Q91338790-C0A339A9-0C3A-41F7-82FA-279C1A490946 @default.
- Q91338790 P356 Q91338790-8D5080E1-70C4-422E-A3BC-0A302EF02D4A @default.
- Q91338790 P478 Q91338790-0C48182F-998C-4DE6-9C49-3B02A44756BF @default.
- Q91338790 P577 Q91338790-77C6C5A5-EBDD-4D3B-95BE-D615D3BE8D9F @default.
- Q91338790 P698 Q91338790-B895F805-C263-4A2D-87F5-E89A869C589E @default.
- Q91338790 P356 J.EXPHEM.2018.08.006 @default.
- Q91338790 P698 30195076 @default.
- Q91338790 P1433 Q5421109 @default.
- Q91338790 P1476 "Ponatinib evaluation and safety in real-life chronic myelogenous leukemia patients failing more than two tyrosine kinase inhibitors: the PEARL observational study" @default.
- Q91338790 P2093 "Agnès Guerci-Bresler" @default.
- Q91338790 P2093 "Aude Charbonnier" @default.
- Q91338790 P2093 "Delphine Rea" @default.
- Q91338790 P2093 "Emilie Cayssials" @default.
- Q91338790 P2093 "Eric Hermet" @default.
- Q91338790 P2093 "Franck E Nicolini" @default.
- Q91338790 P2093 "Françoise Huguet" @default.
- Q91338790 P2093 "Gabriel Etienne" @default.
- Q91338790 P2093 "Lucila Sackmann-Sala" @default.
- Q91338790 P2093 "Lydia Roy" @default.
- Q91338790 P2093 "Marie-Lorraine Chrétien" @default.
- Q91338790 P2093 "Martine Escoffre-Barbe" @default.
- Q91338790 P2093 "Maël Heiblig" @default.
- Q91338790 P2093 "Mohamad Sobh" @default.
- Q91338790 P2093 "Philippe Rousselot" @default.
- Q91338790 P2093 "Shanti Amé" @default.
- Q91338790 P2093 "Stéphane Morisset" @default.
- Q91338790 P2093 "Valérie Coiteux" @default.
- Q91338790 P2093 "Viviane Dubruille" @default.
- Q91338790 P304 "41-48" @default.
- Q91338790 P31 Q13442814 @default.
- Q91338790 P356 "10.1016/J.EXPHEM.2018.08.006" @default.
- Q91338790 P478 "67" @default.
- Q91338790 P577 "2018-09-05T00:00:00Z" @default.
- Q91338790 P698 "30195076" @default.